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SUMMARY
In the UK surveillance of AIDS and HIV infection is based on routine reporting
systems. Whilst attempts are made to ensure that AIDS data are as complete as
possible, numbers of reports fluctuate from month to month for reasons which are
described. In 198G there was an increase in death certificates naming AIDS as a
cause of death in patients who were not identifiable in the surveillance data. More
active surveillance is now undertaken in order to minimize this and other possible
discrepancies.
It is probable that most cases of AIDS are reported and therefore these data can
be used to describe trends in the epidemic by 'risk group'. Laboratory reports of
HIV antibody-positive tests could give an earlier indication of trends because of
the long incubation period of AIDS. But these laboratory data are difficult to
interpret because they represent an incomplete and biased sample of all positive
persons.
AIDS cases are still being reported at a rate which is increasing approximately
exponentially. Short-term predictions are presented showing a growth in the
epidemic which is consistent with previously published predictions. Most cases are
in the homosexual risk group. New asymptomatic homosexual patients with HIV
antibody are still being identified.
The epidemic of AIDS in haemophilia patients should be of finite size although
new cases of AIDS are likely to continue to be diagnosed for several years. AIDS
due to blood transfusion given in the UK before donor screening appears to be a
much smaller epidemic. The epidemic in drug abusers is increasing. Heterosexually
acquired AIDS and HIV infections are being reported in small but increasing
numbers.
INTRODUCTION
In 1982 a voluntary reporting scheme of AIDS cases fulfilling the CDC/WHO
definition was set up at the Communicable Disease Surveillance Centre (CDSC)
and the Communicable Diseases (Scotland) Unit (CD(S)U), and in 1984 a
voluntary laboratory reporting scheme of newly identified patients with HIV
antibody (Galbraith, McEvoy & Sibellas, 198G). Short-term predictions about the
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course of the epidemic have been based on surveillance data in the UK (Tillett &
McEvoy, 1986), although such statistical projections do not take into account
changing epidemiological patterns of the disease. For medium- and long-term
predictions more complex mathematical models are needed although, as yet,
insufficient data are available for estimating parameters for many of the models.
Simple mathematical models which can be used immediately have been
proposed by Bailey (1988), although he stresses that they must not be used in a
rigid manner and that there should also be flexibility in the planning of health care
facilities. Models have been proposed and discussed by Knox (1986) and Anderson
el al. (1986). A more complex computerized simulation system has been developed
(Koch & Welck, 1987), which will allow study of large numbers of variables and
will readily accommodate new information. This system will allow assessments to
be made of the robustness of simplified models.
Special studies are needed, and many are under way, to collect more data. The
experience in other countries is being studied. In the meantime it may be helpful
to demonstrate more fully the data which are already collected. This paper
describes the information available in the UK from routine surveillance and tries
to assess its quality.
MATERIALS
Sources of data
AIDS cases are reported to CDSC on a three-page surveillance form and request
demographic, exposure and clinical data. Reports from Scotland come via the
CD(S)U. All public health and other laboratories in England, Wales and Northern
Ireland are invited to report HIV antibody-positive tests on new patients and
also opportunistic infections associated with HIV infection to CDSC for the
Communicable Disease Report (CDR). A third source of data are death entries
(relating to deaths certified in England and Wales, where over 95 % of UK AIDS
cases are reported) on which AIDS, HIV infection or Kaposi's sarcoma are
recorded as a cause of death. Copies of such entries are supplied by the Office of
Population Censuses and Surveys (OPCS).
Problems with the data
Clinical AIDS surveillance
The aim of the scheme is that these data should be as complete as possible, but
some cases may fail to be reported because of misdiagnosis or because the
physician concerned is not aware of the reporting scheme. Publicity for the scheme
may therefore produce an increase in reporting. Some clinicians do not always
have the manpower immediately available to complete the questionnaires, so that
reporting may be spasmodic.
HIV antibody-positive reports
Although over 100 laboratories report regularly, they can only report those
patients who are tested, and overall this will be a very biased sample, the
completeness of which will vary with risk group. The numbers tested may be
influenced by national or local publicity campaigns. Laboratories report only new
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Month of report
Fig. 1. AIDS cases in UK residents, by month of report.
positive patients, but the same individual may be tested at more than one
laboratory or at the same laboratory with different identification and be reported
more than once. Not all diagnostic laboratories report to the scheme and some
may report incompletely, particularly when pressure of work is greatest.
Death entries
Because these are public property the physician may wish to avoid causing
distress to relatives and give less specific causes of death. These deaths may
therefore not be identifiable as AIDS- or HIV-related and so not made known to
the surveillance scheme.
RESULTS
AIDS in the total population (omitting non-residents)
Up to the end of June 1987 there had been 870 cases reported in the UK for
treatment. The 838 resident cases are shown in Fig. 1 by month of report. There
are non-random fluctuations. For example, the high numbers in July 1986,
January and June 1987 reflect batch reporting from single sources. From January
1987 AIDS was receiving considerable publicity through Government and media
campaigns, also CDSC was piloting a new report form.
The monthly fluctuations may average out if aggregations are made. Table 1
shows cases by quarter and year of report and of diagnosis, where known. A cross-
tabulation is given to demonstrate the time delays from diagnosis of AIDS to the
report being received at CDSC (and accepted as fulfilling the case definition). The
final column gives quarterly diagnoses - the figures in parentheses are numbers of
patients for whom month of diagnosis is unknown but who were diagnosed in that
year. The quarterly diagnoses show the true epidemic curve, but it is incomplete,
especially for recent quarters. (The median interval from diagnosis to report is 2
months, with about 10% having a delay of 12-f months.) However, it is this true
epidemic curve which is required by health care planners.
The bottom row of Table 1 shows quarterly cases by date of report. These data
are complete and would reflect the true epidemic curve (shifted in time) if the
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Table 2. Time of reporting for 774 cases for whom quarter of diagnosis is known
Time of report
Diagnosed
in same
quarter
Diagnosed
previously
Total
1982-
1984
5G
1985
G3
198G
1st
19
I98G
2nd
2G
1980
3rd
23
198(5
4th
1987
1st
41
1987
2nd Total
310
(57%) (45%) (42%) (54%) (27%) (29%) (31%) (41%) (40%)
42 70 20 22 02 02 93 81 404
98 139 45 48 85 87
Xl = 33.3 ( = 0.00002).
134 138 774
distribution of delay times to reporting were unchanging and if reporting was
consistent in its completeness. Both these points will be considered.
Of the 838 cases the quarter of diagnosis is known for 774. These 774 cases are
shown in Table 2, where the delay to reporting is summarized. Overall 310 (40%)
of the 774 cases were diagnosed and reported in the same quarter-year. However,
there have been significant fluctuations over time. The proportions were low in the
second half of 1986, which could be due to current cases failing to be reported or
to the receipt of a larger than usual number of late reports. The proportion was
fairly low in the first quarter of 1987, when CDSC actively sought reports from
centres which had not been able to report recently.
Table 3 shows events in different time periods. Numbers in each row do not
necessarily relate to the same patients. Annual deaths in patients reported to the
scheme have been 6 deaths in 1982, 15 in 1983, 46 in 1984, 103 in 1985, 200 in 1986.
Thus deaths in AIDS cases have been more than doubling each year up until 1986.
Low numbers in recent time periods may reflect the delay in reporting of deaths
or changes in survival times. Numbers of deaths in England and Wales in patients
not known to the surveillance scheme (last column) increased from 16 in 1985 to
58 in 1986. It is possible that some of these were patients who died of HIV
infection without fulfilling the case definition or that a few of them related to the
19 surveillance patients for whom neither the name code nor the date of birth was
recorded. But under-reporting of AIDS may have been on the increase. In 1987
agreement was given from OPCS that the Director of CDSC could approach the
consultant named on the death entry or the doctor who signed the death
certificate of an unreported patient and ask for a surveillance form to be
completed. This scheme is yielding new reports of cases which do fulfil the case
definition.
Predicting AIDS in the total resident population
Short-term predictions for the UK had been made based upon the first
presentation for medical advice (Tillett & MeEvoy, 1986). The date of presentation
was chosen to indicate when health care was required, but experience has shown
that such an indicator is difficult to obtain routinely. Other countries adopted date
of diagnosis (i.e. when the case definition is fulfilled) and so the following analysis
aims to predict future numbers by the date of the patient's diagnosis. Because of
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Table 3. Numbers of reports, diagnosis and deaths in 6-month periods
Deaths
Period
1979-81
1982 Jan.-June
July-Dec.
1983 Jan.-June
July-Dec.
1984 Jan.-June
July-Dec.
1985 Jan.-June
July-Dec.
1986 Jan.-June
July-Dec.
1987 Jan.-June
Total
* New follow-up
date not known.
Cases
reported
—
2
—
8
18
21
55
67
89
111
190
277
838
Cases
diagnosed
4
3
5
5
25
28
66
76
110
147
168
137
774f
Tn reported
No death
entry
1
3
3
2
7
5
11
20
24
49
64
59
248 %
scheme introduced, f Excluding 64, date not
cases
Death
entry
—
—
1
5
10
20
33
26
42
45
34
216
known.
Cases not
•» reported,
i.e. death
entry only
—
—
—
—
—
—
6
10
21
37
Not
applicable*
74
% Excluding 10
the time intervals between diagnosis and report, numbers for recent quarters are
incomplete. Therefore we have used the complete data set of reported cases and
made projections of numbers by date of report. These projections have then been
adjusted for time delays between diagnosis and report to give estimates by date
of diagnoses.
A log-linear regression was performed on quarterly reports from the second
quarter of 1983 (Fig. 2). There is good fit (R2 = 0-95). The estimated new reports
for the last two quarters of 1987 and for each quarter of 1988 are:
1987 (3)
185
1987 (4)
225
1988 (1)
270
1988 (2)
335
1988 (3)
405
1988 (4)
495
The doubling time from the regression equation remains at between 10 and 11
months.
Since the median delay to reporting has been 2 months the above estimates are
lower than the new diagnoses to be expected in that quarter. It should be noted
from Table 1 that a steady increase in reports or in diagnoses has not been
observed - first and second then third and fourth quarters tending to have similar
numbers.
As an approximate estimate of numbers diagnosed, the information from Tables
1 and 2 can be used. On average 40% of the reports in a quarter relate to diagnoses
made in that quarter, 33 % to diagnoses in the previous quarter, 11 % in the one
before that, 8% before that and 16% with longer intervals between diagnosis and
report. For the purposes of this estimation these 1G% have been assigned to the
previous 6-month period.
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100-
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Fig. 2. Log-linear regression of AIDS cases by quarter year of report.
1986 1987
(1st half)
Table 4. Observed and predicted numbers of new AIDS cases in UK residents
(predictions based on numbers known by June 1987)
1987 1988
Observed reports
Predicted reports
Predicted diagnoses*
G50| n /a
G85 1500
880 1900
* N.B. I t is anticipated that all these cases will be reported to the surveillance scheme,
although not all reports will reach CDSC and CD(S)U in the calendar year of diagnosis.
f Provisional figure at mid-December.
Using observed reports in the first two quarters of 1987 and predicted ones
thereafter, the estimated approximate diagnoses in each quarter of 1987 are 160,
190, 240 and 290. Thus about 880 new AIDS diagnoses may be expected in 1987
and, if the exponential phase continues so that the same doubling time pertains,
about 1900 in 1988. These short-term predictions are summarized in Table 4.
In reality there is more than one epidemic taking place, there is spread within
main risk groups and some spread between them. The main risk groups have been
as follows.
The epidemic in homo/bisexual men
This is the largest and longest running epidemic in the UK, consistently
accounting for 87 % of reported cases. Figure 3 shows the cumulative epidemic
curve for homosexuals resident in the UK, by quarter of diagnosis and of report.
Data have been used for the G82 cases for whom date of diagnosis is recorded, the
other 54 cases having been omitted from this graph. The curve for diagnoses looks
as though it is slowing down, but this is because of incompleteness of recent
quarters, where we may expect many more cases to be reported at a later date.
The curve for reports has anomalies due to batch reporting and other problems
previously described. Nevertheless this would be expected to slow down when the
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Fig. 3. Cumulative cases in homosexuals for whom date of diagnosis is known and who
were reported by the end of June 1987 (G82 cases).
exponential phase of the epidemic passes. Although the increase in cases in the
second quarter of 1987 is no larger than that in the first quarter this is no
indication of a slowing down, because this 'seasonal' pattern of similar quarterly
numbers has been observed in previous years (Table 1).
These AIDS data reflect infections which occurred years ago. For current spread
it is necessary to study new HIV infections. Ideally a cohort should be studied,
and such studies in the USA and West Germany provide valuable information. At
CDSC routine laboratory reports from England, Wales and Northern Ireland are
available, and these are shown in Table 5 by time period of report and by presence
or absence of symptoms. For many patients information on risk group or on
symptoms was not available. This problem and the fact that reporting may be
incomplete and that, in some risk groups, most infected patients are never tested
in the early years of their infection mean that this Table has to be interpreted with
caution.
Numbers of reported infected homosexuals increased rapidly through 1985 as
more laboratories acquired diagnostic facilities. Numbers then steadied with an
increase in the first part of 1987, coinciding with the national publicity campaigns.
Numbers tested in every risk group rose sharply at this time, although most were
antibody-negative. This agrees with the finding reported elsewhere that the
'worried well' are easily affected by publicity.
Table 5 shows that, among homosexuals, those found antibody-positive in the
early quarters were more likely to be symptomatic. The majority of patients did
not have AIDS at the time of testing. The main clinical feature was reported to
be lymphadenophathy for half the symptomatic patients. For recent quarters
more patients were asymptomatic than were reported symptomatic.
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Table 5. Laboratory reports of patients with HIV antibody: Eiigland, Wales and
Northern Ireland, up to week 26, 19S7
Years and quarters
Risk group
and symptoms
Homosexual
No
Yes
NK
Total
Haemophilia
No
Yes
NK
Total
TVDA
No
Yes
NK
Total
Other/multiple
No
Yres
NK
Total
Not known
No
Yes
NK
Total
Total
New patients
t
(1st)
9
15
10
34
12
2
51
05
—
—
—
0
1
—
—
1
1
22
20
43
143
1985
(2nd)
12
43
44
99
21
4
93
118
1
2
3
6
2
2
—
4
14
34
32
80
307
(3rd)
17
52
70
139
29
7
65
101
3
2
4
9
2
1
1
4
Gl
57
48
16G
419
(4th)
144
189
109
442
150
12
G7
229
10
9
G
25
4
8
1
13
13
38
50
101
810
(1st)
149
151
12G
42G
28
5
168
201
24
10
1G
50
13
7
13
33
G
24
36
66
776
A
198G
(2nd)
138
117
39
294
14
5
48
67
12
9
18
39
8
15
2
25
3
13
25
41
466
(3rd)
116
116
24
256
7
2
64
73
13
8
13
34
9
12
9
30
4
15
17
36
429
(4th)
127
102
77
306
15
4
55
74
26
11
20
57
13
24
10
47
4
10
24
38
522
1987
(1st)
232
175
58
465
4
4
17
25
38
16
1G
70
33
24
19
76
8
9
22
39
675
(2nd)
171
138
45
354
7
1
10
18
43
23
1G
82
30
28
17
75
15
17
16
48
577
Total
1115
1098
602
2815
287
4G
638
971
170
90
112
372
115
121
72
308
129
239
290
G58
5124
Haemophilia and transfusion-recipient patients
These are considered together because both groups were infected by transfusion
of blood products, and control measures have been introduced. Factor VIII, given
to UK haemophiliacs, has been heat-treated since mid-1985. Blood for transfusion
in the UK has been screened for HIV antibody since October 1985 and there is also
a high degree of self-exclusion from donating blood if the donor may be in a risk
group.
AIDS cases are shown in Table G. The epidemic in haemophilia patients is
increasing quite fast. There are fewer cases in blood transfusion recipients trans-
fused in the UK.
Many haemophilia patients who have received Factor VIII are being monitored
for HIV infection. Table 5 shows that 971 had been reported to CDSC infected but
without AIDS by the end of week 26, 1987 (approximately the end of June). Few
new infections are now being reported.
In the 'other/multiple' risk group in Table 5, 44 patients had multiple risk
factors, and of the remainder only 48 were reported as transfusion recipients, of
whom 13 were stated to have no symptoms. The country of transfusion is not
always stated.
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Table G. AIDS cases in recipients of blood and blood products
Year
1983
1984
1085
198G
1987 (first half)
(Year NK)
Total
Haemophilia
patients
A
Reports Diagnosis
2 2
1 5
G 8
1G 14
14 G
— (4)
39 39
(0
Reports
3
1
2
6
Transfusion
in UK
K
\
Diagnoses
1
2
3
G
recipients
(ii)
i
Reports
2
3
1
G
abroad
Diagnoses
1
1
2
1
(1)
G
Intravenous drug abusers (IVDAs)
The number of reported AIDS cases is increasing - one was diagnosed in 1983,
2 in 1984, 0 in 1985, 9 in 198G and 6 by June in 1987. For one the year of diagnosis
is not known. Twelve of these 25 patients were also homosexuals. In laboratory
reports of HIV positivity IVDAs are the only known risk group where numbers
were higher for the second than for the first quarter of 1987. Just under 10% of
total antibody positive reports are from female patients, but half these females are
reported to be IVDAs.
Heterosexually spread epidemic
There were 20 AIDS cases out of the 838 in which the patient's infection was
thought to have been acquired heterosexually. Seven of these were reported to
have been due to sexual contact in the UK and three of the seven were contacts
of high-risk partners (one haemophiliac and two IVDAs). One was diagnosed in
1983, two in 1985, two in 1986 and two diagnosed by June in 1987. In the 'other'
risk groups of Table 5 the majority of patients were reported as probably having
acquired their infection through heterosexual contact. For many patients
information on place of exposure is incomplete, but where travel of contact abroad
was mentioned, Africa was commonly cited.
Six reported AIDS cases were not in the above risk groups, four of them were
children born to infected mothers who had acquired their infection through blood
transfusion, drug abuse or heterosexually.
DISCUSSION
It appears that a high proportion of persons infected with HIV are likely to
develop AIDS; as the length of cohort studies increases so does the progression
rate to AIDS. For example, in San Francisco a cohort study of homosexuals shows
only 24% to be asymptomatic after 6 years of infection, and after 8 years about
40% have AIDS (Hessol et al. 1987). There is no evidence of the progression rate
slowing down.
At the December 1986 European Community meeting in Bilthoven on AIDS
prediction (proceedings to be published) it was apparent that all countries with an
AIDS epidemic experience an exponential phase for the first years. Very short-
term predictions can be made using this epidemic curve, whether using log-linear
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regression or a generalized linear mode. The two methods give similar results with
UK data (Healy & Tillett, 1988). Statistical confidence limits are questionable for
a single country's predictions when there is such similarity between countries. In
Greece this observation has led them to use a Bayesian approach. Furthermore,
the accuracy of extrapolation is affected by the quality of the surveillance data
used.
In the UK the quality of the surveillance data make formal statistical
extrapolations and confidence intervals hard to interpret. Various factors
(publicity, extra staff at the surveillance centre, scrutiny of death certificates)
may have resulted in more complete reporting of AIDS in 1987. If so, this is not
reflected in an obvious acceleration of the epidemic curve. This could be
interpreted as either that the true epidemic curve is slowing down or that the
increase of effort in maintaining the surveillance is only matching the increase of
the epidemic itself. The completeness of reporting, and particularly the consistency
of that completeness, affect the confidence with which this epidemic curve can be
extrapolated.
In practice, a logarithmic plot of quarterly reports shows a remarkabl}7 steady
linear trend, which would seem to justify short-term extrapolations. A statistical
regression was used for this purpose although an arbitrary decision was made to
omit the first few observations where numbers were small and the rate of increase
is affected by a positive 'transient' (Gonzalez & Koch, 1987), which is an anomaly
due to the long incubation period whereby the rate of increase in cases at the
beginning of the epidemic is artificially greater than had been the true spread of
infection. These surveillance data are being used to make tentative projections
without confidence limits for the reasons discussed. They suggested that about
another 410 AIDS cases will be reported finally in 1987, bringing the annual total
to about 685, with about 1500 new reports expected in 1988. At the time of going
to press (mid-December) the actual total reports for 1987 are 650.
For the purposes of planning it is preferable to express numbers by date of
diagnosis rather than report. This has to be done by applying the average lag
times observed previousi}'. These lag times have fluctuated significantly, and so
this averaging introduces another approximation into the forecasting. The
observations suggest that just under 900 new AIDS cases will be diagnosed during
1987 and 1900 in 1988. These numbers are lower than those predicted in
November 1986 (Tillett & McEvoy) of 1300 in 1987 and 3000 in 1988, but these
latter were by date of first presentation for medical advice, which is often several
months before diagnosis and would therefore be expected to be much larger. Many
patients first presented at the time of onset of early HIV-related symptoms. The
doubling time remains similar, and so these revised predictions are compatible
with the earlier published figures, the differences being due to using a different
date in the patients' illnesses.
The UK epidemic is currently dominated by AIDS cases in the homosexual risk
group. The future course of this epidemic is likely to follow the features of those
in the USA. The San Francisco epidemic is particularly well documented and has
provided data for modelling (e.g. van Druten, 1986; Bailey, 1988). In the UK, as
elsewhere, the AIDS cases are reflecting the spread of HIV several years ago. As
the numbers of susccptibles diminish the exponential phase of the epidemic must
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end, and a slowing down in the rate of increase of new cases will be seen. Changes
in the 'high risk' sexual behaviour are also likely to slow the spread and there was
extensive health education in this community, from an early date, organized by
voluntary groups and later by government campaigns. A third cause of slowing
down is the negative 'transient', which compensates for the positive 'transient'
seen at the beginning of the AIDS epidemic.
When log-linearity ends and there is inflexion in the AIDS epidemic curve it will
be possible to add one more parameter to short-term statistical projections. In the
meantime projections beyond 1988 have to be very tentative. The doubling time
of new AIDS cases of 10 to 11 months cannot continue indefinitely among the
current main risk group, the homosexual population. But a doubling every 12 or
even 24 months still implies large numbers of new cases annually.
As yet among homosexuals there is little evidence from clinical surveillance
data that the AIDS epidemic is slowing down in the UK. It will be important to
see whether the numbers reported in the next quarters are higher or lower than
expected (being 1G0 and 195 for the third and fourth quarters of 1987 - calculated
as 87 % of total predicted residential cases by date of report) and whether about
40% of those (65 and 75) will have been diagnosed in that same quarter, although
the significance of departures from expected is open to debate. Statistical
probabilities cannot be assigned. At the time of going to press the numbers of new
homosexual resident cases reported in the third quarter of 1987 were 149, of whom
55 were diagnosed during that quarter.
Current laboratory reports of newly diagnosed HIV infections include many
asymptomatic homosexuals. Such patients are more likely to have been recently
infected than those with symptoms (excluding those symptoms associated with
seroconversion). New HIV infections in this risk group have not stopped, but it
seems common sense to assume that they are no longer increasing exponentially.
The AIDS epidemic in recipients of blood and blood products given in the UK
is perhaps more predictable. Intervention to prevent both epidemics was made in
1985. Progression rates to AIDS could be postulated for cohorts infected before
intervention. It is likely that both epidemic curves will be of similar shape and
timing, although the magnitude of the transfusion-associated epidemic looks to be
much smaller than that among haemophilia patients. Few new infections are being
reported in haemophiliacs now through the laboratory reporting scheme, although
about a thousand had been previously. These laboratory data together with the
AIDS surveillance data suggest that the transfusion epidemic will be small. By
mid-1987 there had been six UK transfusion-associated cases reported, compared
with 39 AIDS cases in haemophiliacs. A very few transfusion cases could still arise
from screened blood which is infective but not detected by the tests used. AIDS
due to transfusion abroad is far more unpredictable.
AIDS cases and laboratory reports of HIV antibody are increasing among
intravenous drug abusers. Many are known to be infected in Scotland (Robertson,
1985) and many must be infected in the rest of the UK but never tested because
they are asymptomatic. This epidemic is hard to predict and is likely to increase
exponentially for several years, being in its early stages.
In the USA the heterosexual epidemic is following the same pattern as that for
the homosexual epidemic, but following a few years behind (Robertson, White &
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Bnrgmann, 1988). If the same were to occur in the UK 'this would affect AIDS
projections substantially. Any indication of heterosexual spread from high-risk
groups and then between heterosexuals must be sought. Studies can be targeted.
At the third international conference on AIDS, Washington 1987, papers were
presented which supported the hypotheses that heterosexual spread is more likely
if the patients have genital ulcers (Katzenstein et al. 1987) or if the index case has
an HIV infection which has already progressed to pre-AIDS symptoms (Goedert,
Eyster & Biggar, 1987).
The authors wish to thank everyone who reports to the surveillance schemes
and the staff at CD(S)U and CDSC who process the data.
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